Concepedia

The Prevalence of DPYD*9A (c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis

Anu S. Maharjan, Gwendolyn A. McMillin, Girijesh Kumar Patel, Saad Awan, William R. Taylor, Sachin Gopalkrishna Pai, Arthur E. Frankel, Cindy Nelson, Bin Wang, Peter J. Hosein,

Clinical Colorectal Cancer · 2019 · 18 citations · 30 references

DOI

Concepts

References

30

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

, , +9

Capecitabine as Adjuvant Treatment for Stage III Colon Cancer

Chris Twelves, A. Wong, Marek P. Nowacki et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

, , +17

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

Glen D. Heggie, Jean‐Pierre Sommadossi, David S. Cross et al. · PubMed · 1987 · 731 citations

, , +17

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis

Linda M. Henricks, Carin A.T.C. Lunenburg, Femke M. de Man et al. · The Lancet Oncology · 2018 · 419 citations · Full text

, , +16

Familial Pyrimidinemia and Pyrimidinuria Associated with Severe Fluorouracil Toxicity

Mendel Tuchman, Joel S. Stoeckeler, David T. Kiang et al. · New England Journal of Medicine · 1985 · 250 citations

, , +13